Compounds > 1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)-
Page last updated: 2024-09-02

1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- and Alloxan Diabetes

1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- has been researched along with Alloxan Diabetes in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aonuma, K; Homma, S; Islam, M; Jesmin, S; Kamiyama, J; Maeda, S; Maruyama, H; Miyauchi, T; Miyauchi, Y; Mizutani, T; Rahman, A; Sakai, S; Shimojo, N; Zaedi, S1
Johns, EJ; Wongmekiat, O1
Goto, K; Jesmin, S; Maeda, S; Masuzawa, K; Miyauchi, T; Shimojo, N; Zaedi, S1
Hattori, Y; Iemitsu, M; Jesmin, S; Maeda, S; Masuzawa, K; Miyauchi, T; Mowa, CN; Shimojo, N; Yamaguchi, N; Zaedi, S1
Brennan, P; Fouyas, IP; Kelly, PA; Whittle, IR1

Other Studies

5 other study(ies) available for 1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- and Alloxan Diabetes

ArticleYear
Effects of selective endothelin (ET)-A receptor antagonist versus dual ET-A/B receptor antagonist on hearts of streptozotocin-treated diabetic rats.
    Life sciences, 2014, Aug-28, Volume: 111, Issue:1-2

    Topics: Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Echocardiography; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Heart; Heart Ventricles; Indans; Insulin; Male; Nitric Oxide Synthase Type III; Pyrimidines; Rats; Rats, Sprague-Dawley; Sulfonamides; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2014
Endothelin as a causative factor of blunted volume reflex in diabetic rats.
    British journal of pharmacology, 2003, Volume: 138, Issue:8

    Topics: Animals; Blood Volume; Diabetes Mellitus, Experimental; Endothelin Receptor Antagonists; Endothelins; Indans; Kidney; Male; Rats; Rats, Wistar; Receptors, Endothelin; Reflex

2003
Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
    Experimental biology and medicine (Maywood, N.J.), 2006, Volume: 231, Issue:6

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Indans; Intercellular Adhesion Molecule-1; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Time Factors; Vascular Endothelial Growth Factor A

2006
Endothelin antagonism normalizes VEGF signaling and cardiac function in STZ-induced diabetic rat hearts.
    American journal of physiology. Endocrinology and metabolism, 2007, Volume: 292, Issue:4

    Topics: Animals; Capillaries; Coronary Vessels; Diabetes Mellitus, Experimental; Echocardiography; Endothelin Receptor Antagonists; Endothelins; Heart; Indans; Male; Myocardium; Nitric Oxide Synthase Type III; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Vascular Endothelial Growth Factor A

2007
The role of endothelin in the cerebrovascular response following intracerebral haemorrhage: experimental studies using the endothelin antagonist SB209670.
    British journal of neurosurgery, 2008, Volume: 22, Issue:1

    Topics: Animals; Cardiovascular Agents; Cerebral Hemorrhage; Cerebrovascular Circulation; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Hematoma; Indans; Rats; Rats, Inbred BB

2008